
逍遥散对皮质酮诱导的PC12损伤模型保护作用及神经保护成分分析验证研究
孙璐, 吴亚运, 刘丽娟, 赵亚, 黎雄, 赵瑞芝, 胡巧红
逍遥散对皮质酮诱导的PC12损伤模型保护作用及神经保护成分分析验证研究
Study on the protective effect of Xiaoyaosan on corticosterone-induced PC12 injury model and its neuroprotective components
目的 通过探究逍遥散的神经保护作用及其化学组成,发现逍遥散中可能发挥神经保护作用的有效活性成分。 方法 采用水提法提取逍遥散,通过高分辨质谱-液相色谱质谱联用仪分析提取液的化学成分;制备逍遥散含药血清;构建皮质酮(Corticosterone,CORT,400 μmol/L)诱导PC12细胞损伤模型,检测含药血清对PC12细胞增殖率的影响;用SIMCA软件进行细胞增殖率-成分含量相关性分析,找到逍遥散中可能具有神经保护作用的化合物。 结果 与模型组相比,逍遥散含药血清可减轻CORT诱导的细胞损伤,并促进细胞增殖(P=0.000)。液质谱图结合软件分析比对发现,主要药效化合物有:芍药苷、甘草酸、甘草苷、迷迭香酸、没食子酸、2-苯基乙醛、(15Z)-9,12,13-Trihydroxy-15-octadecenoic acid、丹酚酸B、甘草皂苷G2等,单体验证结果显示苯乙醛具有一定的神经保护作用(P=0.000)。 结论 证明逍遥散具有神经保护作用,分析并鉴定出55种化合物有可能是其发挥作用的主要成分,发现逍遥散中未曾报道的7种可能具有神经保护作用的化合物,并验证出苯乙醛具有神经保护作用且此前从未报道。本研究成果将为阐明逍遥散神经保护作用的物质基础提供参考,也为拓展逍遥散的临床应用提供数据支撑。
Objective To study the neuroprotective effect of Xiaoyaosan and its chemical composition,and to identify the active ingredients in Xiaoyaosan responsible for neuroprotection. Methods Xiaoyaosan was extracted using water,and the chemical composition of extract was analyzed using high-resolution mass spectrometry and liquid chromatography. Moreover,we prepared Xiaoyaosan-containing serum and established a corticosterone(CORT,400 μmol/L) -induced PC12 cell injury model to evaluate the impact of the drug-containing serum on the proliferation rate of PC12 cells. Then we used SIMCA software to analyze the correlations between cell proliferation rate and drug components to identify the compounds in Xiaoyaosan that may have neuroprotective effects. Results Compared with the model group,the drug-containing serum could reduce the cell injury induced by CORT and promote cell proliferation(P=0.000). Analysis of liquid chromatography-mass spectrometry data in software showed that the main medicinal compounds were:paeoniflorin,glycyrrhizic acid,liquiritin,rosmarinic acid,gallic acid,2-phenylacetaldehyde,(15Z)-9,12,13-trihydroxy-15-octadecenoic acid,salvianolic acid B,and licorice saponin G2. The experimental results of individual compounds showed that phenylacetaldehyde was effective in neuroprotection(P=0.000). Conclusion This research proves that Xiaoyaosan has neuroprotective effect. Fifty-five compounds were identified as potential ingredients involved in neuroprotection. Seven compounds,previously unreported and possessing potential neuroprotective properties,were identified in Xiaoyaosan. In addition,we demonstrate that phenylacetaldehyde has a neuroprotective effect,which has not been reported. The results of this study provide a reference for elucidating the material basis of the neuroprotective effect of Xiaoyaosan,and also provide data support for expanding the clinical application of Xiaoyaosan.
Xiaoyaosan / neuroprotective effect / chemical composition
R285
1 |
丁竹松. 加味逍遥散的临床应用体会[J]. 大家健康(学术版),2014,8(8):52-53.
|
2 |
张明瑞,王 镁. 王镁教授运用富碘中药联合逍遥散加减治疗甲亢经验总结[J]. 亚太传统医药,2023,19(4):129-133.
|
3 |
俞 芹. 临床应用逍遥散的体会[J]. 世界中医药,2009,4(1):40-41.
|
4 |
|
5 |
石博宇,刘 蓉,饶志粒,等. 逍遥散对LPS所致大鼠神经损伤的保护作用机制[J]. 中国实验方剂学杂志,2019,25(5):50-56.
|
6 |
张莹林,姚俊岩. 神经炎症在阿尔茨海默病中作用的研究进展[J]. 国际麻醉学与复苏杂志,2022,43(1):90-94.
|
7 |
|
8 |
杨厚增,赵鸿君,任 路. 中医对焦虑障碍证候的经典名方治疗及其机理研究[J]. 中华中医药学刊,2023:1-12.
|
9 |
吴佳佳,卞庆来,丁凤敏,等. 逍遥散抗抑郁作用的研究进展[J]. 中华中医药学刊,2023:1-11.
|
10 |
张碧涛,李媛媛,辛泰然,等. 逍遥散治疗抑郁症的研究进展[J]. 中国实验方剂学杂志,2022,28(23):273-282.
|
11 |
刘加河,洪冠宇,纪春敏,等. 逍遥散治疗糖尿病合并抑郁症的疗效观察[J]. 糖尿病新世界,2018,21(10):77-78,81.
|
12 |
李云开. 逍遥散加减治疗中风后抑郁症的临床疗效观察[J]. 中国医药指南,2013,11(31):345-346.
|
13 |
李劲松. 晚期癌症患者治疗中逍遥散抗抑郁的疗效观察[J]. 医学理论与实践,2013,26(24):3267-3268.
|
14 |
李琼锋,杜义斌,赵 义. 立论于肝脾同治研究逍遥散对老年性痴呆模型鼠行为学及神经可塑性的影响[J]. 世界中医药,2017,12(5):1124-1127.
|
15 |
富文俊,曹国平,富丽俊. 慢性应激触发帕金森病神经损伤的分子生物学机制及调肝方药逍遥散保护作用的探讨[J]. 时珍国医国药,2017,28(1):239-242.
|
16 |
|
17 |
|
18 |
|
19 |
|
20 |
|
21 |
|
22 |
|
23 |
|
24 |
|
25 |
|
/
〈 |
|
〉 |